EX-1.1
from 8-K
41 pages
930,000 Shares of Common Stock, 13,350 Shares of Series a Convertible Preferred Stock (Convertible Into 2,670,000 Shares of Common Stock) and Warrants (Exercisable Into 1,800,000 Shares of Common Stock) of Catalyst Biosciences, Inc. Underwriting Agreement
12/34/56